FDA warns of young blood



[ad_1]

The US FDA has issued a warning regarding plasma infusions of young donors for profit, advising consumers to be cautious about the possibility of infusing young blood in establishments listed in their safety instructions. published on Tuesday, February 19, 2019.

Depending on their facility, institutions in several states offer older people plasma infusions from younger donors, some of whom claim that they can help reverse the effects of aging and treat various diseases. Although parabiosis has been effective in animal studies, the FDA has warned that their claims do not rely on any human evidence and suggest that the procedure is badociated with "infectious, allergic, respiratory and cardiovascular. "

In a statement, Scott Gottlieb and Peter Marks of the FDA say "We are concerned that some patients are falling prey to unscrupulous actors touting plasma treatments of young donors as remedies and cures" but do not mention any "Actors" in the press release.

One of the parabiosis transfusion centers (young blood) was Ambrosia, based in California, which announced its intention to terminate the patient's treatment. The start-up was discovered by Jesse Karmazin, inspired by animal studies on the effects of mixing young and old blood on surgically-joined mice, which yielded very promising results. According to the Huffington Post, the clinic charged $ 8,000 for transfusions for a two-liter large-scale treatment. This treatment may not have been affordable for everyone, but the pricing would have been expensive, and the company suggests not getting any revenue for the moment.

In an interview with Mic Karmazin would have been quoted as follows: "I want to be clear, at this point it works, it reverses aging. We are pretty clear at this point. It's conclusive … probably with the clinical trial, it worked so well that we'll start treating people … it works, there's really no question of whether it works or not. "

However, some doctors and researchers have expressed doubts about his confidence and are skeptical about his findings, believing that there is no published study showing that the treatment is effective and does not pose any health risks. . and the FDA declares "There is no clinically proven benefit of plasma infusions of young donors" "..plasma is not approved by the FDA to deal with other conditions … not guided by evidence from adequate and well-controlled studies … " and encourage people to report any adverse effects badociated with the administration of plasma in any clinic.

[ad_2]
Source link